Key Highlights

  • Rocket Lab executed its inaugural dedicated European Space Agency (ESA) mission on March 28.
  • The “Daughter Of The Stars” operation successfully placed ESA’s “Celeste” payload into low Earth orbit at 510 km altitude.
  • This mission represented RKLB’s sixth orbital delivery of 2026 and the 85th flight for the Electron launch vehicle.
  • The company secured a $190 million contract from the U.S. Department of War for 20 hypersonic test missions — representing its most valuable single agreement — elevating total backlog beyond $2 billion.
  • Analysts maintain a Moderate Buy rating on RKLB with a mean price target of $89.36, suggesting approximately 47% potential appreciation.

Rocket Lab achieved a significant milestone Friday evening by executing its inaugural dedicated European Space Agency mission, delivering a dual-satellite payload to orbit from its New Zealand facility. The Electron launch vehicle departed from Launch Complex 1 at 10:14 p.m. NZT on March 28, transporting ESA’s “Celeste” payload to a 510 km low Earth orbit.

The operation carried the designation “Daughter Of The Stars.” This flight represents the company’s sixth orbital mission of 2026 and brings the Electron vehicle’s total mission count to 85.

The dual-satellite payload will evaluate whether a constellation operating in low Earth orbit can function effectively with Europe’s Galileo navigation system, which operates from medium Earth orbit. This demonstration aims to enhance positioning precision throughout Europe for applications spanning autonomous transportation, maritime operations, and emergency response services.

The spacecraft originated from two separate European industrial teams — one under GMV’s leadership in Spain and another directed by Thales Alenia Space in France.


RKLB Stock Card
Rocket Lab USA, Inc., RKLB

RKLB stock advanced approximately 2% during Monday’s premarket session following the mission announcement.

Shares have declined 13% since the beginning of the year, influenced by widespread market caution and escalating U.S.-Iran tensions. Looking at the trailing twelve-month period, the equity has surged 231%.

Major Contract Bolsters Company Position

Alongside this successful launch, Rocket Lab finalized a $190 million agreement with the U.S. Department of War to conduct 20 hypersonic test missions utilizing its HASTE launch platform. This agreement stands as the company’s most substantial individual contract to date.

The arrangement elevated Rocket Lab’s aggregate backlog beyond the $2 billion threshold.

The company’s 2026 manifest includes upcoming missions spanning commercial Earth observation platforms, national security operations, international space agency projects, and hypersonic technology validation.

Neutron Development Remains Central Focus

These ongoing operations precede the highly anticipated inaugural flight of Rocket Lab’s Neutron rocket, scheduled for late 2026.

Neutron aims to address the medium-lift launch segment, featuring reusable architecture designed for larger commercial and government payloads.

Analysts assign RKLB a Moderate Buy consensus rating, comprising nine Buy recommendations and four Hold ratings. The mean price target stands at $89.36 — representing approximately 47% upside potential from present trading levels.